Free Trial

Comerica Bank Acquires 33,973 Shares of Maximus, Inc. $MMS

Maximus logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • Comerica Bank increased its stake in Maximus by 124.4%, buying 33,973 shares to hold 61,284 shares worth about $5.29 million after the quarter.
  • Institutional investors own 97.21% of Maximus; CFO David Mutryn bought 1,000 shares (now owns 40,037) while analysts have trimmed ratings to a consensus Hold, and the company announced a $0.33 quarterly dividend (2.0% yield).
  • Five stocks we like better than Maximus.

Comerica Bank grew its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 124.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 61,284 shares of the health services provider's stock after acquiring an additional 33,973 shares during the quarter. Comerica Bank owned 0.11% of Maximus worth $5,290,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. Dimensional Fund Advisors LP boosted its position in shares of Maximus by 2.0% in the third quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider's stock valued at $170,812,000 after acquiring an additional 36,989 shares during the period. Boston Partners boosted its position in shares of Maximus by 47.0% in the third quarter. Boston Partners now owns 966,139 shares of the health services provider's stock valued at $88,236,000 after acquiring an additional 308,892 shares during the period. Reinhart Partners LLC. boosted its position in shares of Maximus by 0.8% in the third quarter. Reinhart Partners LLC. now owns 921,578 shares of the health services provider's stock valued at $84,206,000 after acquiring an additional 7,722 shares during the period. Stephens Investment Management Group LLC boosted its position in shares of Maximus by 49.0% in the third quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider's stock valued at $65,873,000 after acquiring an additional 237,097 shares during the period. Finally, Federated Hermes Inc. boosted its position in shares of Maximus by 1.3% in the third quarter. Federated Hermes Inc. now owns 688,505 shares of the health services provider's stock valued at $62,909,000 after acquiring an additional 8,847 shares during the period. Institutional investors own 97.21% of the company's stock.

Insider Activity at Maximus

In related news, CFO David Mutryn bought 1,000 shares of Maximus stock in a transaction that occurred on Monday, February 9th. The shares were acquired at an average cost of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the acquisition, the chief financial officer directly owned 40,037 shares of the company's stock, valued at approximately $3,027,597.94. The trade was a 2.56% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Jan Madsen sold 742 shares of the company's stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total value of $53,609.50. Following the completion of the sale, the director owned 20,795 shares in the company, valued at $1,502,438.75. The trade was a 3.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.80% of the stock is currently owned by company insiders.

Analyst Ratings Changes

MMS has been the subject of a number of recent research reports. Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Monday, February 23rd. Zacks Research cut shares of Maximus from a "strong-buy" rating to a "hold" rating in a research report on Monday, April 27th. Finally, Weiss Ratings cut shares of Maximus from a "buy (b)" rating to a "hold (c+)" rating in a research report on Tuesday, February 24th. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Maximus has a consensus rating of "Hold".

Get Our Latest Report on MMS

Maximus Stock Performance

Maximus stock opened at $65.55 on Friday. The business has a 50 day moving average of $69.28 and a 200-day moving average of $80.47. Maximus, Inc. has a 1 year low of $60.75 and a 1 year high of $100.00. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.34 and a quick ratio of 2.34. The company has a market capitalization of $3.58 billion, a P/E ratio of 9.98 and a beta of 0.60.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.01. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.37 billion. During the same quarter in the prior year, the firm posted $1.61 earnings per share. The firm's revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, equities research analysts predict that Maximus, Inc. will post 8.46 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Friday, May 15th will be issued a $0.33 dividend. The ex-dividend date is Friday, May 15th. This represents a $1.32 annualized dividend and a yield of 2.0%. Maximus's dividend payout ratio is presently 20.09%.

About Maximus

(Free Report)

Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

See Also

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines